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Early Cellular Effects of Circulating
Cadmium-Thionein on Kidney Proximal
Tubules
by Katherine S. Squibb,* James W. Ridlington,tt
Neil G. Carmichael,t and Bruce A. Fowlert
Circulating cadmium-thionein (Cd-MT) is cleared from the mammalian circulatory system by filtration
through the kidney glomerulus with subsequent reabsorption by kidney proximal tubules. Damage to the
tubules results following uptake ofCd-MT, which is dependent upon time and the dose level ofcadmium
administered. Intravenous administration of109Cd-MT at doses of 0.017 and 0.17 mg Cd/kg body weight
with examination oftotal renal uptake of109Cd at 0.5, 3, and 24 hr disclosed that the rate ofclearance from
the blood and uptake by the kidney was sinificantl more rapid at the 0.017 mg Cd/kg dose. Ultrastruc-
tural changes resulting from intravenous injection ofeither form A or B ofCd-MT were characterized by
increased numbers ofpinocytotic vesicles and small, dense lysosomal structures. There was no evidence of
mitochondrial swelling or cell death at either 3 or 6 hr after injection. The subcellular distribution of
cadmium in kidney tissue at various times after administration of Cd-MT was determined by using
differential centrifugation techniques with 109Cd and insitu by using x-ray microanalysis. At 30 min after
injection of Cd-MT, significant amounts of cadmium were present in lysosomal fractions indicating an
interaction between the tubular lysosome system and Cd-MT prior to the onset ofovert cellular toxicity.
Results suggest that Cd-MT is reabsorbed and broken down by kidney tubule cells in a physiological
manner with possible subsequent release of the toxic cadmium ion.
Introduction
Studies of the involvement of metallothionein
(MT) in the metabolism of cadmium have shown
that this protein plays a major role in determining
the pharmacokinetics and toxicity of the cadmium
ion in mammalian systems (1). Attention has re-
cently turned to studies of the metabolism of the
cadmium-thionein (Cd-MT) protein complex itself,
however, because of the nephrotoxic properties of
this compound (2-4). Following injection or oral
exposure to Cd 2, cadmium in plasma is primarily
bound to the high molecular weight proteins alpha-
2-macroglobulin and albumin (5). The ion is prefer-
entially cleared from the blood stream by the liver
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(3). Plasma cadmium bound to the low molecular
weight (6000-7000) thionein molecule, however, is
reabsorbed by the kidney (6) leadingto damage to the
proximal tubules (4).
Although Cd-MT normally accumulates in liver
and kidney tissues as an intracellular metallopro-
tein, recent evidence suggests that Cd-MT might
also be present in blood under certain circum-
stances. Data reported by Ridlington and co-
workers (7) suggest that cadmium is slowly translo-
cated from the liver to the kidney over a 6 month
period following short-term exposure to cadmium.
Release ofcadmium from the liver with transport to
the kidney is thought to occur via circulating
Cd-MT (1, 8). In support of this, Hirayama and
Shaikh (9) have demonstrated the presence of
Cd-MT in the circulatory system at 4 weeks after
the start ofcontinuous cadmium exposure. Cherian
and co-workers (10) have suggested a second possi-
ble source ofcirculating Cd-MT to be the intestinal
lumen following dietary exposure to Cd-MT.
This study was undertaken to examine the early
morphological effects of intravenously injected
287Cd-MT on renal proximal tubules and the interac-
tion ofcadmium with subcellular organelles in order
to study the mechanism by which circulating
cadmium-thionein is reabsorbed by the kidney
proximal tubule and its relationship to Cd-MT-
induced renal toxicity.
Methods
Preparation of Cd-MT
Male Sprague-Dawley rats (CD strain, obtained
from Charles River Laboratories) weighing 250-300
g were injected subcutaneously with 0.5 mg Cd as
CdCl2 in 0.9% (w/v) NaCl daily for 5 days and were
sacrificed two days after the last injection. Hepatic
Cd-MT was prepared by Sephadex G-75 gel fitra-
tion of liver-soluble proteins. For certain experi-
ments, the MT fractions were further purified by
DE52 cellulose anion exchange chromatography to
obtain components MT-A and MT-B (11). Prepara-
tions of MT were lyophilized following dialysis
against deionized water for 18 hr.
When 109Cd-labeled Cd-MT was prepared, rats
were injected as above with 0.1 mg Cd as CdCl2 and
0.25 ,uCi '09Cd per injection.
Cadmium concentrations were determined by
using a Jarrel Ash 850 atomic absorption spec-
trophotometer. 109Cd activity was measured in a
Beckman Biogamma II gamma ray spec-
trophotometer.
Analysis of Cd-MT-Induced Morphological
Changes in Kidney Proximal Tubule Cells
Male Sprague-Dawley ratsweighing 100-120gwere
injected with Cd-MT intravenously usingthe saphen-
ous vein. Groups offive rats each were injected with
either 0.18 mg Cd as Cd-MT-A or 0.17 mg Cd as
Cd-MT-B per kg body weight in a volume of0.1 ml
and were sacrificed after 3 or 6 hr. Control rats were
injected with saline. Immediately following sacrifice
by exsanguination, slices ofkidney cortex were fixed
and processed for electron microscopy as previously
described (12). Kidneycadmiumconcentrations from
the same animals were determinedby atomic absorp-
tion spectrometry ofsamples prepared by dry ashing
at 450°C for 24 hr.
Subcellular Distribution of Cadmium
Rats weighing 100-200 g were divided into six
groups ofthree rats each and injected intravenously
with either 0.17 mg Cd as '09Cd-MT (0.02 uCi) or
0.017 mg Cd as 109Cd-MT (0.002 ,uCi) per kg body
weight. Groups of rats were sacrificed 0.5, 3, or 24
hr after injection. One entire kidney ofeach rat was
quickly counted for total radioactivity in a gamma
ray spectrophotometer. Kidney homogenates were
prepared from both kidneys by using 3 ml of0.25M
sucrose-0.OlM Tris/HCl buffer (pH 7.4) pergram of
tissue with four strokes of a Potter-Elvejhem
homogenizer. Homogenates were fractionated by
centrifugation to obtain the following six fractions:
15OOg x min pellet (fraction I); 7500g x min pellet
(fraction II); 42,800g x min pellet (fraction III);
292,000g x min pellet (fraction IV); 3,600,000g x
min pellet (fraction V); and the 3,60,000g x min
supernatant fraction (fraction VI). All fractions
were washed once with the homogenizing buffer
and the wash combined with the corresponding su-
pernatant fraction. Each pellet was resuspended in
2 ml of 0.01M Tris/HCl (pH 7.4) buffer, and the
radioactivity measured in a Beckman gamma
counter. Aliquots (2 ml) of homogenates and frac-
tion VI were counted in a similar fashion. Acid
phosphatase activity of the fractions was measured
according to the procedure of Turnbull and Neil
(13). Proteins were measured by the method of
Lowry et al. (14) by using bovine serum albumin as
a standard.
Energy-Dispersive X-Ray Microanalysis
of Subcellular Cadmium
Three male rats weighing 175-200 g were injected
intraperitoneally with 0.64 mg Cd as Cd-MT per kg
body weight and sacrificed after 3 hr. Slices ofkid-
ney cortex were fixed and processed for x-ray mi-
croanalysis as previously described (15). The x-ray
spectra were obtained over specific subcellular
structures by using an EDAX energy-dispersive
x-ray analysis system attached to a Phillips EM 300
using an accelerating voltage of 80 KeV.
Statistical Analysis
Analyses of significant differences were made by
using a one-way analysis of variance test (16).
Results and Discussion
Experiments in this study were designed to
evaluate the early effects of Cd-MT on rat kidney
proximal tubule cells. Previous studies by a number
of investigators (2, 4, 17) have demonstrated the
renal toxicity of intravenously injected Cd-MT. Ul-
trastructural morphometric studies (4) of kidneys
from rabbits injected with Cd-MT have shown that a
dose of0.4 mg/kg Cd as Cd-MT produced extensive
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FIGURE 1. Electron micrograph of a proximal tubule cell from a control rat showing the nucleus (N), mitochondria (M), brush border
(arrow) and normal complement oflysosomes and apical vacuoles. x 12,700.
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FIGURE 2. Electron micrograph ofa proximal tubule cell from a rat injected with 0.18 mg Cd/kg body weight as Cd-MT-A 3 hr prior to
sacrifice showing an increased number of pinocytotic vesicles and small dense lysosomal structures. x 16,320.
290 Environmental Health PerspectivesFIGURE 3. Electron micrograph ofa kidney proximal tubule cell from a rat injected with 0.18 mg Cd/kg body weight as Cd-MT-A 6 hr
prior to sacrifice showing an increased number of vesicles and dense lysosomal structures. x 16,375.
February 1979 291Table 1. Kidney cadmium concentration following
intravenous injection of Cd-MT or CdCL2.a
Time after Cd, ,Lg/g tissueb
injection, hr MT-A MT-B CdCI2 Saline
3 9.5c. e + 1.5 10.8c ± 1.4 1.3d ± 0.3 0.9 ± 0.1
6 9.lc e ± 0.1 1.08c ± 1.1 .Id + 0.1 0.8 ± 0.1
a Rats were injected intravenously with 0.18 mg Cd as Cd-
MT-A or 0.17 mg Cd as Cd-MT-B or 0.20 mg Cd/kg body weight
as CdC12 3 or 6 hr prior to sacrifice. Control rats were injected
with O.9o (w/v) NaCI. Total kidney cadmium concentrations
were determined as outlined in the Methods section.
b Means ± S.D.; n = 5.
c Indicates the number is significantly different from the
saline-injected group (p < 0.05).
d Indicates the number is not significantly different from the
saline-injected group (p < 0.05).
e Indicates the number is not significantly different from the
MT-B-injected group (p < 0.05).
Table 2. Relationships between dose, time, and uptake of Cd-MT
by kidney tissue.a,b
Administered Kidney cadmium Time after
Cd dose, mg/kg Total,ug % ofdose injection, hr
0.017 3.2c.d 30.8 0.5
6.3c,d 62.0 24
0.17 9.g^,d 9.6 0.5
21.3c 20.6 3
28.6d 27.7 24
a Rats were injected intravenously with 0.17 mg Cd or 0.017
mg Cd/kg body weight as u09Cd-MT at 0.5, 3 or 24 hr prior to
sacrifice. Total kidney cadmium was calculated by using the
specific activity ofthe injected 109Cd-MT.
b Numbers with the same superscript are significantly different
(p < 0.05).
tubular necrosis, as evidenced by degeneration of
cytoplasmic organelles, leading to renal failure
within 7 days. In the present study, rat kidneys
were examined following administration of Cd-MT
at lower doses and at shorter time periods after
Cd-MT injection to assess early changes which
occur in kidney proximal tubule cells following
reabsorption ofCd-MT but prior to the onset ofcell
degeneration.
The normal architecture ofa proximal tubule cell
from acontrol rat is illustrated in Figure 1. The most
striking change observed in proximal tubule cells
from rats injected with either Cd-MT-A or Cd-
MT-B 3 hr prior to sacrifice was an increase in the
number ofsmall vesicles and small dense lysosomal
bodies near the apical portion of the cell (Fig. 2).
There was no evidence of cell death at this time.
Mitochondria did not appear swollen and plasma
and nuclear membranes appeared to be intact. The
same morphological changes were observed fol-
lowing injection of either form of MT. Also, rats
injected with either MT-A or MT-B showed no dif-
ferences in the reabsorption of Cd-MT based on
renal concentrations ofCd (Table 1). Such evidence
indicates that the two forms of MT are similar in
their interaction with the kidney and that the mor-
phological changes observed are not due to a
specific form of Cd-MT. Data in Table 1 also show
that there was essentially no kidney uptake of Cd
following injection of CdCl2, which is consistent
with work reported by other investigators (2, 3).
Figure 3 illustrates a kidney proximal tubule cell
obtained from a rat injected 6 hr previously with
Cd-MT-A. Afurtherincrease in the numberofsmall
dense lysosomes and small vesicles is apparent
compared to the changes observed after 3 hr. Signs
of cell necrosis are still not evident. These mor-
phological changes suggest that Cd-MT interacts
with the kidney lysosomal system following reab-
sorption of the protein. The following series of ex-
periments were designed to study the uptake of
Cd-MT by the proximal tubule cell.
Data in Table 2 show the relationship which
exists between dose level and kidney uptake of
Cd-MT. Following an intravenous injection of
Cd-MT at a dose of 0.17 mg Cd/kg body weight,
9.6% ofthe injected dose is taken up by the kidneys
after 30 min; by 3 hr after injection, 20.6% is recov-
ered in the kidneys. The amount present at 24 hr is
not significantly different than that at 3 hr, which
suggests that the injected Cd-MT had been cleared
from circulation by 3 hr. This is consistent with the
data presented in Figure 4 which show that detecta-
ble levels of"*Cd were present in serum at 30 min
after injection, but by 3 hr serum '"Cd activity had
returned to background levels. In contrast to the
high dose of Cd-MT, a dose of0.017 mg Cd per kg
body weight was reabsorbed more efficiently by the
kidneys; by 24 hr a total of 62% had been reab-
sorbed. These data show that the Cd-MT reabsorp-
tion system is saturable, in agreement with data re-
ported by Foulkes (18). Loss ofCd-MT in the urine,
as reported by Cherian and co-workers (3), would be
expected to occurwhen large amounts ofCd-MT are
injected.
To study the mechanism of uptake of Cd-MT by
kidney tubule cells, the subcellular distribution of
Cd was measured after intravenous injection of
0"Cd-MT. Data showing the association of "*Cd
with various subcellular fractions obtained by dif-
ferential centrifugation at various times after injec-
tion ofCd-MT are given in Table 3. At 30 min after
injection of '"Cd-MT, "*Cd was recovered in all
fractions, the largest percentage associated with the
crude nuclear fraction (fraction I). The three frac-
tions composed predominantly of lysosomes and
mitochondria (fractions II-IV) together accounted
for about 38% of the total Cd present in the tissue.
Environmental Health Perspectives 292By 3 hr after injection ofMT, the relative amount of
Cd associated with the lysosomal-mitochondrial
fractions had decreased considerably. Fraction I Cd
remained approximately the same, while the pro-
portion of Cd present in the soluble fraction of the
cell had increased from 25% to 62%. By 24 hr, there
was a decrease in Cd associated with fraction I and
a corresponding increase in soluble Cd. The
lysosomal-mitochondrial fractions remained un-
changed.
The column in Table 3 labeled "control" was
obtained by addition of109Cd-MT to excised control
rat kidneys prior to homogenization. The amount
added was equal to that present in the 3 hr injected
group. This control group measures the nonspecific
binding ofCd-MT to cellular fractions following dis-
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FIGURE 4. Serum u09Cd activity at various times after intravenous
injection of 0.17 mg Cd/kg body weight as l09Cd-MT.
ruption of the cell. Although the majority of the
Cd-MT was recovered in the soluble fraction, a sig-
nificant proportion of cadmium (14%) was recov-
ered in fraction I, due probably to absorption ofthe
Cd-MT molecule to either plasma or nuclear mem-
branes. Only small amounts of Cd were recovered
in fractions 11-V.
By using the control group as a baseline, it is
evident that Cd does associate with the lyso-
somal-mitochondrial fractions of the cell after in-
jection ofCd-MT. Table 4 shows the dataexpressed
as total weight of Cd associated with each fraction.
At all three time periods, 0.5, 3, and 24 hr, the ac-
tual amount of cadmium associated with fractions
II-IV was greater than that which could be ac-
counted for by the control group. The greatest as-
sociation of Cd with the lysosomal-mitochondrial
fractions occurred at 0.5 hr, the earliest time period
measured after injection.
When the data are expressed on a concentration
basis (as %Cd/% protein, Table 5), it is evident that
after 30 min, the cadmium was most concentrated in
fractions I and III. These two fractions also had
relatively high acid phosphatase activities, an en-
zyme normally used as a marker forlysosomes. The
fact that cadmium is concentrated in fraction III
rather than the lighter lysosomal fraction would
suggest that Cd-MT is present in heavier lysosomes
possibly derived from the fusion of pinocytotic
vesicles with lighter primary lysosomes.
It is difficult to interpret the significance of the
cadmium present in fraction I. The relatively high
concentration of acid phosphatase and cadmium in
this fraction could be due to the presence of large
Table 3. Subcellular distribution of'09Cd following intravenous injection of l09Cd-MT.a
Cadmium content offraction at various
Centrifugation times following Cd-MT injection, % of injected dose"
Subcellular speed, 0.5 3 24 Predominant
fraction g x min hr hr hr Control composition
I 1,500 33.2 ± 0.6r 30.2 ± 3.2c 22.4 + 2.4c 14.2 ± 0.5 Nuclei, large
cytoplasmic bodies
II 7,500 14.3 ± 1.1I 2.7 ± 0.3c 2.7 ± 0.5 1.4 ± 0.3 Mitochondria,
lysosomes
III 42,800 18.3 ± 0.8r 1.6 ± 0.2 1.7 ± 0.4 0.9 ± 0.1 Mitochondria,
lysosomes
IV 292,000 6.0 ± 0.6f 1.9 ± 0.2r 1.7 ± 0.2 0.6 ± 0.1 Mitochondria,
lysosomes
V 3,600,000 2.5 ± 0.1I 1.7 ± 0.l 1.0 ± 0.1 0.4 ± 0.2 Microsomes, Small mito-
chondria, lysosomes
VI 3,600,000 25.6 ± l.8 61.8 ± 5.4 70.4 ± 5.6 82.5 ± 1.4 Cytoplasmic sap
a Rats were injected intravenously with 0.17 mg Cd/kg body weight as109Cd-MT at 0.5, 3, or 24 hrpriorto sacrifice. Control rats were
injected with 0.9o (w/v) NaCl and '09Cd-MT was added to the kidneys at the time of homogenization. Subcellular fractions were
prepared as outlined in the Methods section. Assignment of the predominant composition of the fractions was made according to
Maack et al. (19).
b S.E.M.,n = 3.
c Indicates the number is significantly different (p < 0.05) than the control value for the same fraction.
February 1979Table 4. Total cadmium content of subcellular fractions of the kidney.a
Subcellular Cd at various times after injection, ,ug/fractionb
fraction 0.5 hr 3 hr 24 hr Control
I 2.86 + 05b 5.13 + 0.55 4.29 ± 0.47 2.24 ± 0.08
II 1.24 ± 0.10 0.46 ± 0.04 0.53 ± 0.11 0.22 ± 0.04
III 1.58 ± 0.07 0.28 ± 0.04 0.32 ± 0.08 0.14 ± 0.02
IV 0.52 ± 0.05 0.33 ± 0.04 0.32 ± 0.04 0.10 ± 0.01
V 0.22 ± 0.01 0.29 + 0.02 0.20 ± 0.02 0.07 ± 0.03
VI 2.22 + 0.20 10.48 ± 0.92 13.47 ± 1.07 13.04 ± 0.23
Rats were injected intravenously with 0.17 mg Cd/kg body weight as "09Cd-MT at 0.5, 3, or 24 hr prior to sacrifice. Control rats were
injected with 0.9%o (w/v) NaCl, and '09Cd-MT was added to the kidneys at the time of homogenization. Subcellular fractions were
prepared as outlined in the Methods section.
b S.E.M.; n = 3.
Table 5. Relative content of cadmium in subcellular fractions
of the kidney following intravenous injection of Cd-MT."
Cd concn at various times Acid
after injection, % Cd/% protein phosphatase,
Subcellular % activity/
fraction 0.5 hr 3 hr 24 hr Control % protein
I 2.24 2.04 1.51 0.96 1.29
II 0.64 0.12 0.12 0.06 0.90
III 1.44 0.13 0.13 0.07 1.42
IV 0.59 0.18 0.16 0.06 1.49
V 0.32 0.22 0.12 0.05 1.17
VI 0.93 2.26 2.56 3.01 0.71
Rats were injected intravenously with 0.17 mg Cd/kg body
weight as '09Cd-MT at 0.5, 3, or 24 hr prior to sacrifice. Control
rats were injected with 0.9% (w/v) NaCl, and '09Cd-MT was
added to the kidneys at the time of homogenization. Subcellular
fractions were prepared as outlined in the Methods section.
lysosomal-type cytoplasmic bodies, as suggested by
Maack and co-workers (19). However, adsorption
of Cd-MT to components ofthis fraction and/or the
presence of unbroken cells may give rise to con-
tamination of this fraction. It is also possible that
released Cd ions may have entered the nuclei (20).
It should also be noted that cadmium present in the
soluble fraction (fraction VI) could arise from a
numberofsources, such as disruption ofsubcellular
organelles containing Cd-MT or from Cd-MT pre-
sent in the tubular lumen or extracellular spaces at
the time of homogenization. Therefore, a precise
analysis of the subcellular localization of Cd in situ
cannot be obtained from this type of experiment
alone.
The x-ray microanalysis ofkidney tissue for cad-
mium supported the suggestion that Cd-MT is taken
up by lysosomes following reabsorption ofthe pro-
tein by the kidney proximal tubular cells. Figure 5 is
a picture of the cathode ray display of the x-ray
monitor unit obtained following analysis of a dense
lysosomal structure in a proximal tubule cell from a
rat injected with 0.64 mg Cd/kg body weight as
Cd-MT 3 hr prior to sacrifice. After background
subtraction (Fig. 6), a small but significant peak was
left at the position of the Cd La line. Although we
were working very close to the detection limits of
the x-ray analysis unit on our electron microscope
with these tissues, we did regularly obtain small
peaks for Cd which remained following background
subtraction when lysosomes were analyzed. Suchin
situ localization of cadmium within lysosomes sup-
ports the biochemical location of cadmium within
this organelle after Cd-MT reabsorption. Because
the cells did not show signs ofnecrosis at the short
time intervals used in these experiments, the as-
sociation ofCd with lysosomes should be indicative
ofthe reabsorption mechanism for Cd-MT and can-
not be attributed to an association of Cd resulting
from the irreversible processes of cell death.
Data from these studies suggest that circulating
Cd-MT is reabsorbed by kidney proximal tubules by
the same mechanisms involved in reabsorption of
other low molecular weight plasma proteins (21).
The increase in pinocytotic vesicles and small lyso-
somes and the association of Cd with lysosomal
fractions suggests that Cd-MT is reabsorbed by the
kidney via pinocytosis and is broken down by lyso-
somes following fusion ofthe vesicles with primary
lysosomal bodies. Such a process is consistent with
data reported by Cherian and Shaikh (6) on the deg-
radation ofinjected 35S-labeled Cd-MT. Ofthe solu-
ble reabsorbed thionein, 60% was degraded by 3 hr
after injection. This rate of degradation is consid-
erably greater than that reported by Oh et al. (22)
for the normal turnover of Cd-MT in the kidney
which was approximately 3.5 days. This difference
in rates of degradation would suggest that Cd-MT
reabsorbed by the kidney cell is more rapidly as-
sociated with the degradative lysosomal system
than Cd-MT synthesized within the cell itself. Deg-
radation of the protein following reabsorption is
also consistent with what is presently known about
the uptake of proteins by kidney proximal tubular
cells in general (23-25). There is little convincing
evidence to date to suggest that any proteins are
reabsorbed and transported across the cell in their
Environmental Health Perspectives 294Flll ili III P iL 1
FIGURE 5. Energy-dispersive x-ray spectra from a lysosomal
structure in a proximal tubule cell of a rat injected IP 3 hr
prior to sacrifice with 0.64 mg Cd/kg body weight as Cd-MT.
The marked line is the Cd La peak (3.13 KeV).
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FIGURE 6. Energy dispersive x-ray spectra following computer
background subtraction from a lysosome in a renal proximal
tubule cell ofa rat injected with 0.64 mgCd/kg body weight as
Cd-MT. The Cd La peak in significant above background
with a 2 a confidence interval.
intact form (25).
Although the mechanism of the toxic action of
Cd-MT on the kidney is not well understood, results
ofthis study suggest that Cd ions released in orfrom
lysosomes following degradation of Cd-MT are re-
sponsible for the development of tubular necrosis.
Fowler and Nordberg (4) have previously suggested
that toxic Cd ions are released from lysosomes in
excess of the amount of apothionein present inL
proximal tubule cells available to resequester the
ions, thus leading to cell death. Mego and Cain (26)
have reported that Cd inhibits proteolysis in
heterolysosomes in vivo. It is possible, therefore,
that Cd ions remaining within the lysosomes might
inhibit lysosomal function and thereby lead to cell
death via a mechanism involving the inability ofthe
cell to degrade other reabsorbed proteins such as
albumin with a resultant loss of control over in-
tracellular osmotic conditions.
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